Plasma samples were collected according to standard procedures in the clinical routine. Samples were then rapidly frozen for permanent storage at −80°C.
22 (link) Plasma levels of pTau variants pTau‐181 and pTau‐231 were quantified using a custom Single molecule array (Simoa) assay as previously described.
22 (link) pTau‐217+ was quantified by Janssen R&D.
23 (link) Plasma NTA‐tau concentrations were quantified using an in‐house–developed Simoa immunoassay using a Simoa HD‐X platform (Quanterix) at the Clinical Neurochemistry Laboratory (Mölndal, Sweden). Development and validation of the NTA assay has been previously described.
9 (link) In brief, plasma NTA assay is comprised by a mouse monoclonal antibody with epitope 6‐18aa (Tau12, BioLegend) used as a detector and a mouse monoclonal antibody with epitope 159‐163aa (HT7, Thermo Scientific) used as the capture antibody.